|
Dr. Elizabeth G. Nabel, MD
Elizabeth
G. Nabel, M.D. is Director of the
National Heart, Lung, and Blood
Institute at the National Institutes
of Health. Dr. Nabel oversees an
extensive national research
portfolio with an annual budget of
approximately $3.0 billion to
prevent, diagnose, and treat heart,
lung, and blood diseases. A native
of St. Paul, Minnesota, she
conducted her cardiology training at
Brigham and Women’s Hospital,
Harvard Medical School, followed by
faculty positions at the University
of Michigan Medical School where she
directed the Division of Cardiology
and the Cardiovascular Research
Center. As a cardiovascular
physician-scientist, Dr. Nabel has
made many contributions to basic and
clinical research on the
pathogenesis and treatment of
cardiovascular diseases, especially
the molecular genetics of vascular
diseases. She has delineated the
mechanisms by which cell cycle and
growth factor proteins regulate the
proliferation of vascular cells in
blood vessels, a process important
for the development of
atherosclerosis and other
cardiovascular diseases. Dr. Nabel
is an elected member of the
Institute of Medicine of the
National Academy of Sciences, the
American Society of Clinical
Investigation, and the Association
of American Physicians. She has
received numerous awards for her
scientific accomplishments and
several honorary degrees. Dr. Nabel
has served on the editorial board of
many scientific journals, the New
England Journal of Medicine,
Science, and the Journal of Clinical
Investigation. A partner on 13
patents, Dr. Nabel is the author of
more than 200 scientific
publications, and she has mentored
more than 45 students and fellows. |
